Poly Medicure Limited Share Price & Analysis
₹1,695.9▼ -1.45%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹1,695.9
-1.45%
Open
₹—
High
₹1,721.8
Low
₹1,691
Close
₹1,695.9
52W High
₹2,145
52W Low
₹1,182
Volume
41K
Lot Size
1
Sector
Healthcare
Market Cap
₹17K Cr
Face Value
₹5
Mid CapNIFTY 500
Price Chart
Fundamentals
P/E
52
Sector P/E
54.4
P/B
4.31
EPS
₹31.75
ROE
11.2%
ROCE
14%
D/E Ratio
0.11
Div Yield
0.21%
Book Value
₹306
+
Strengths
- ✓Low debt relative to equity (D/E 0.1x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
POLYMED · as of Mar 2026
Promoters62.44%
FII11.46%▼0.87
DII11.96%▲0.30
Public14.13%▲0.56
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 53.17% | 53.14% | 66.02% | 62.56% | 62.44% | 62.44% |
| FII | 14.10% | 12.37% | 9.91% | 11.88% | 12.33% | 11.46% |
| DII | 5.46% | 7.21% | 9.34% | 12.33% | 11.66% | 11.96% |
| Public | 27.28% | 27.25% | 14.72% | 13.23% | 13.57% | 14.13% |
Corporate Events
Dividend - Rs 3.50 Per Share
Dividend17 Sept 2025
Annual General Meeting/Dividend - Rs 3 Per Share
Dividend18 Sept 2024
Annual General Meeting/Dividend - Rs 3 Per Share
Dividend20 Sept 2023
Latest News
All news →Poly Medicure faces Delhi HC stamp duty matter
*Poly Medicure faces Delhi HC stamp duty matter*\nPoly Medicure Limited is involved in a case at the Delhi High Court concerning a stamp duty matter. The issue pertains to regulatory compliance and could lead to financial liability depending on the outcome. While not immediately threatening operations, it may affect investor sentiment near-term.\n\n📊 *STOCKS:* POLYMEDIC | 🏢 *SECTOR:* Pharma | #LOWIMPACT #legal
NSE Filing8 Jul
Poly Medicure schedules investor and analyst call
*Poly Medicure schedules investor and analyst call.* The company has announced a scheduled interaction for investors and analysts. Such calls are typically for sharing operational updates or strategic developments. No financial figures or major announcements were disclosed. 📊 *STOCKS:* POLYMEDIC | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorCall
NSE Filing22 Jun
Poly Medicure to host investor meet, no major updates
Poly Medicure announced a schedule for its upcoming Investors/Analysts Meet. The event aims to provide general corporate updates. No significant financial or operational developments were disclosed. *Investors may expect routine disclosures without immediate market-moving triggers.* 📊 *STOCKS:* POLYMED | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet
NSE Filing10 Jun
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹535 Cr ▲8.3% | ₹494 Cr ▲11.3% | ₹444 Cr ▲10.2% | ₹403 Cr ▼8.6% | ₹441 Cr ▲4.0% | ₹424 Cr ▲1.0% | ₹420 Cr ▲9.1% | ₹385 Cr |
| Op. Profit | ₹110 Cr ▼0.9% | ₹111 Cr ▼3.5% | ₹115 Cr ▲8.5% | ₹106 Cr ▼10.9% | ₹119 Cr ▲4.4% | ₹114 Cr ▼0.9% | ₹115 Cr ▲10.6% | ₹104 Cr |
| OPM | 21.0% ▼8.7% | 23.0% ▼11.5% | 26.0% ▲0.0% | 26.0% ▼3.7% | 27.0% ▲0.0% | 27.0% ▲0.0% | 27.0% ▲0.0% | 27.0% |
| Net Profit | ₹65 Cr ▼8.5% | ₹71 Cr ▼22.8% | ₹92 Cr ▼1.1% | ₹93 Cr ▲1.1% | ₹92 Cr ▲8.2% | ₹85 Cr ▼2.3% | ₹87 Cr ▲17.6% | ₹74 Cr |
| EPS (₹) | 6.54 ▼6.6% | 7 ▼22.7% | 9.06 ▼1.4% | 9.19 ▲1.4% | 9.06 ▲7.7% | 8.41 ▼2.5% | 8.63 ▲11.9% | 7.71 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.9K Cr ▲12.3% | ₹1.7K Cr ▲21.4% | ₹1.4K Cr ▲23.3% | ₹1.1K Cr ▲20.9% | ₹922 Cr ▲17.5% | ₹785 Cr ▲14.3% | ₹687 Cr ▲12.6% | ₹610 Cr ▲17.5% | ₹519 Cr ▲14.3% | ₹454 Cr |
| Expenses | ₹1.4K Cr ▲18.0% | ₹1.2K Cr ▲19.7% | ₹1.0K Cr ▲19.7% | ₹847 Cr ▲19.8% | ₹707 Cr ▲24.3% | ₹569 Cr ▲9.4% | ₹520 Cr ▲8.6% | ₹479 Cr ▲20.7% | ₹397 Cr ▲10.0% | ₹361 Cr |
| Op. Profit | ₹442 Cr ▼2.9% | ₹455 Cr ▲26.0% | ₹361 Cr ▲35.2% | ₹267 Cr ▲24.2% | ₹215 Cr ▼0.5% | ₹216 Cr ▲30.1% | ₹166 Cr ▲26.7% | ₹131 Cr ▲7.4% | ₹122 Cr ▲31.2% | ₹93 Cr |
| OPM | 24.0% ▼11.1% | 27.0% ▲3.8% | 26.0% ▲8.3% | 24.0% ▲4.3% | 23.0% ▼17.9% | 28.0% ▲16.7% | 24.0% ▲9.1% | 22.0% ▼4.3% | 23.0% ▲9.5% | 21.0% |
| Other Income | ₹119 Cr ▲26.6% | ₹94 Cr ▲56.7% | ₹60 Cr ▲57.9% | ₹38 Cr ▼5.0% | ₹40 Cr ▲81.8% | ₹22 Cr ▲4.8% | ₹21 Cr ▲5.0% | ₹20 Cr ▲25.0% | ₹16 Cr ▲14.3% | ₹14 Cr |
| Interest | ₹18 Cr ▲28.6% | ₹14 Cr ▲0.0% | ₹14 Cr ▲27.3% | ₹11 Cr ▲83.3% | ₹6 Cr ▼45.5% | ₹11 Cr ▼45.0% | ₹20 Cr ▲42.9% | ₹14 Cr ▲16.7% | ₹12 Cr ▲50.0% | ₹8 Cr |
| Depreciation | ₹116 Cr ▲39.8% | ₹83 Cr ▲31.7% | ₹63 Cr ▲10.5% | ₹57 Cr ▲5.6% | ₹54 Cr ▲12.5% | ₹48 Cr ▲17.1% | ₹41 Cr ▲10.8% | ₹37 Cr ▲27.6% | ₹29 Cr ▲20.8% | ₹24 Cr |
| PBT | ₹427 Cr ▼5.7% | ₹453 Cr ▲31.7% | ₹344 Cr ▲45.1% | ₹237 Cr ▲21.5% | ₹195 Cr ▲8.3% | ₹180 Cr ▲42.9% | ₹126 Cr ▲26.0% | ₹100 Cr ▲3.1% | ₹97 Cr ▲29.3% | ₹75 Cr |
| Tax % | 25.0% ▲0.0% | 25.0% ▲0.0% | 25.0% ▲0.0% | 25.0% ▲0.0% | 25.0% ▲0.0% | 25.0% ▲4.2% | 24.0% ▼31.4% | 35.0% ▲29.6% | 27.0% ▲0.0% | 27.0% |
| Net Profit | ₹321 Cr ▼5.3% | ₹339 Cr ▲31.4% | ₹258 Cr ▲44.1% | ₹179 Cr ▲21.8% | ₹147 Cr ▲8.1% | ₹136 Cr ▲41.7% | ₹96 Cr ▲47.7% | ₹65 Cr ▼8.5% | ₹71 Cr ▲29.1% | ₹55 Cr |
| EPS (₹) | 31.78 ▼4.9% | 33.41 ▲24.2% | 26.91 ▲44.0% | 18.69 ▲22.3% | 15.28 ▲7.8% | 14.17 ▲30.5% | 10.86 ▲46.6% | 7.41 ▼7.4% | 8 ▲28.0% | 6.25 |
| Div Payout | 11.0% ▲10.0% | 10.0% ▼9.1% | 11.0% ▼31.3% | 16.0% ▲0.0% | 16.0% ▼11.1% | 18.0% ▲0.0% | 18.0% ▼33.3% | 27.0% ▲8.0% | 25.0% ▼37.5% | 40.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹51 Cr ▲0.0% | ₹51 Cr ▲6.3% | ₹48 Cr ▲0.0% | ₹48 Cr ▲0.0% | ₹48 Cr ▲0.0% | ₹48 Cr ▲9.1% | ₹44 Cr ▲0.0% | ₹44 Cr ▲0.0% | ₹44 Cr ▲0.0% | ₹44 Cr |
| Reserves | ₹3.1K Cr ▲12.5% | ₹2.7K Cr ▲90.9% | ₹1.4K Cr ▲19.1% | ₹1.2K Cr ▲14.8% | ₹1.0K Cr ▲13.3% | ₹918 Cr ▲134.8% | ₹391 Cr ▲16.0% | ₹337 Cr ▲14.6% | ₹294 Cr ▲29.5% | ₹227 Cr |
| Borrowings | ₹354 Cr ▲96.7% | ₹180 Cr ▲3.4% | ₹174 Cr ▲16.8% | ₹149 Cr ▲17.3% | ₹127 Cr ▼7.3% | ₹137 Cr ▼33.8% | ₹207 Cr ▲28.6% | ₹161 Cr ▲21.1% | ₹133 Cr ▲31.7% | ₹101 Cr |
| Other Liabilities | ₹459 Cr ▲86.6% | ₹246 Cr ▲14.4% | ₹215 Cr ▲15.0% | ₹187 Cr ▲14.7% | ₹163 Cr ▲34.7% | ₹121 Cr ▼4.0% | ₹126 Cr ▲12.5% | ₹112 Cr ▲19.1% | ₹94 Cr ▲10.6% | ₹85 Cr |
| Total Liabilities | ₹3.9K Cr ▲22.8% | ₹3.2K Cr ▲71.7% | ₹1.9K Cr ▲17.9% | ₹1.6K Cr ▲14.5% | ₹1.4K Cr ▲12.5% | ₹1.2K Cr ▲59.6% | ₹767 Cr ▲17.3% | ₹654 Cr ▲15.8% | ₹565 Cr ▲23.6% | ₹457 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹1.7K Cr ▲57.0% | ₹1.1K Cr ▲25.0% | ₹867 Cr ▲36.5% | ₹635 Cr ▲30.1% | ₹488 Cr ▲14.6% | ₹426 Cr ▲17.4% | ₹363 Cr ▲18.6% | ₹306 Cr ▲15.5% | ₹265 Cr ▲28.0% | ₹207 Cr |
| CWIP | ₹91 Cr ▼9.9% | ₹101 Cr ▲32.9% | ₹76 Cr ▼2.6% | ₹78 Cr ▲81.4% | ₹43 Cr ▲104.8% | ₹21 Cr ▼16.0% | ₹25 Cr ▲31.6% | ₹19 Cr ▲5.6% | ₹18 Cr ▼10.0% | ₹20 Cr |
| Investments | ₹755 Cr ▼29.9% | ₹1.1K Cr ▲544.9% | ₹167 Cr ▲32.5% | ₹126 Cr ▼63.6% | ₹346 Cr ▼2.3% | ₹354 Cr ▲1316.0% | ₹25 Cr ▲212.5% | ₹8 Cr ▼52.9% | ₹17 Cr ▲466.7% | ₹3 Cr |
| Other Assets | ₹1.4K Cr ▲47.4% | ₹930 Cr ▲24.3% | ₹748 Cr ▲1.4% | ₹738 Cr ▲47.9% | ₹499 Cr ▲18.2% | ₹422 Cr ▲19.2% | ₹354 Cr ▲10.3% | ₹321 Cr ▲21.6% | ₹264 Cr ▲16.3% | ₹227 Cr |
| Total Assets | ₹3.9K Cr ▲22.8% | ₹3.2K Cr ▲71.7% | ₹1.9K Cr ▲17.9% | ₹1.6K Cr ▲14.5% | ₹1.4K Cr ▲12.5% | ₹1.2K Cr ▲59.6% | ₹767 Cr ▲17.3% | ₹654 Cr ▲15.8% | ₹565 Cr ▲23.6% | ₹457 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹246 Cr ▲2.5% | ₹240 Cr ▼9.8% | ₹266 Cr ▲39.3% | ₹191 Cr ▲55.3% | ₹123 Cr ▲3.4% | ₹119 Cr ▼9.2% | ₹131 Cr ▲23.6% | ₹106 Cr ▲41.3% | ₹75 Cr ▲33.9% | ₹56 Cr |
| Investing CF | ₹-225 Cr ▲81.2% | ₹-1.2K Cr ▼395.4% | ₹-241 Cr ▼34.6% | ₹-179 Cr ▼110.6% | ₹-85 Cr ▲80.5% | ₹-436 Cr ▼300.0% | ₹-109 Cr ▼7.9% | ₹-101 Cr ▼14.8% | ₹-88 Cr ▼57.1% | ₹-56 Cr |
| Financing CF | ₹20 Cr ▼97.9% | ₹951 Cr ▲4855.0% | ₹-20 Cr ▼53.8% | ₹-13 Cr ▲62.9% | ₹-35 Cr ▼111.0% | ₹317 Cr ▲1609.5% | ₹-21 Cr ▼320.0% | ₹-5 Cr ▼131.3% | ₹16 Cr | ₹0 Cr |
| Net Cash Flow | ₹41 Cr ▲1466.7% | ₹-3 Cr ▼160.0% | ₹5 Cr ▲600.0% | ₹-1 Cr ▼133.3% | ₹3 Cr | ₹0 Cr ▼100.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▼66.7% | ₹3 Cr | ₹0 Cr |
| Free Cash Flow | ₹-59 Cr ▲33.7% | ₹-89 Cr ▼888.9% | ₹-9 Cr ▲81.3% | ₹-48 Cr ▼54.8% | ₹-31 Cr ▼229.2% | ₹24 Cr ▼4.0% | ₹25 Cr ▼19.4% | ₹31 Cr ▲542.9% | ₹-7 Cr | ₹0 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 103d ▲35.5% | 76d ▲5.6% | 72d ▼6.5% | 77d ▼6.1% | 82d ▲13.9% | 72d ▲5.9% | 68d ▼11.7% | 77d ▼2.5% | 79d ▲2.6% | 77d |
| Inventory Days | 265d ▲13.7% | 233d ▲13.7% | 205d ▼13.5% | 237d ▲8.7% | 218d ▲0.5% | 217d ▼10.0% | 241d ▲29.6% | 186d ▲15.5% | 161d ▼17.0% | 194d |
| Days Payable | 75d ▲5.6% | 71d ▼20.2% | 89d ▼15.2% | 105d ▼8.7% | 115d ▲3.6% | 111d ▼21.8% | 142d ▲15.4% | 123d ▲28.1% | 96d ▼26.7% | 131d |
| Cash Conv. Cycle | 294d ▲23.0% | 239d ▲27.1% | 188d ▼10.0% | 209d ▲13.0% | 185d ▲3.4% | 179d ▲7.8% | 166d ▲19.4% | 139d ▼3.5% | 144d ▲2.9% | 140d |
| Working Capital Days | 249d ▲236.5% | 74d ▲37.0% | 54d ▼21.7% | 69d ▼14.8% | 81d ▲9.5% | 74d ▲76.2% | 42d ▼25.0% | 56d ▼21.1% | 71d ▲29.1% | 55d |
| ROCE | 14.0% ▼30.0% | 20.0% ▼16.7% | 24.0% ▲33.3% | 18.0% ▲5.9% | 17.0% ▼22.7% | 22.0% ▼12.0% | 25.0% ▲13.6% | 22.0% ▼15.4% | 26.0% ▲8.3% | 24.0% |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Poly Medicure Limited share price today?▾
Poly Medicure Limited (POLYMED) is currently trading at ₹1,695.9 on NSE, down 1.45% as of the last market session. Prices update daily after market close on MarketNetra.
Is Poly Medicure Limited available in F&O (Futures & Options)?▾
Yes, Poly Medicure Limited (POLYMED) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Poly Medicure Limited 52-week high and low?▾
Poly Medicure Limited's 52-week high is ₹2,145 and the 52-week low is ₹1,182. The current price of ₹1,695.9 is 20.9% below the 52W high.
What is Poly Medicure Limited P/E ratio?▾
Poly Medicure Limited's current P/E ratio is 52. This indicates the market is paying ₹52 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Poly Medicure Limited options?▾
Poly Medicure Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade POLYMED options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.